(Q37287548)

19 August 2017

Breast radiation therapy guideline implementation in low- and middle-income countries (English)

1 reference

Adaptive radiation therapy

19 August 2017

0 references

3

Ashwini Budrukkar

1 reference

19 August 2017

2

Anusheel Munshi

1 reference

19 August 2017

Nuran Senel Bese

1

1 reference

19 August 2017

Ahmed Elzawawy

series ordinal

4

1 reference

19 August 2017

Carlos A Perez

series ordinal

5

1 reference

19 August 2017

Breast Health Global Initiative Radiation Therapy Focus Group

series ordinal

6

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

19 August 2017

1 reference

19 August 2017

113

1 reference

19 August 2017

8 Suppl

1 reference

19 August 2017

2305-2314

1 reference

The impact of central lung distance, maximal heart distance, and radiation technique on the volumetric dose of the lung and heart for intact breast radiation.

19 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: final results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: an analysis of prospective data from British

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

Long-term outcomes in breast cancer patients with ten or more positive axillary nodes treated with combined-modality therapy: the importance of radiation field selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: a randomized Phase III trial of the International Atomic Energy Agency (IAEA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

Multimodality image registration quality assurance for conformal three-dimensional treatment planning

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: Implications for postmastectomy radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studie

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Spectrum of breast cancer in Asian women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Radiation therapy in Africa: distribution and equipment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Quantitative status of resources for radiation therapy in Asia and Pacific region.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Overview of radiotherapy resources in Latin America: a survey by the International Atomic Energy Agency (IAEA).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Radiotherapy for breast cancer in countries with limited resources: program implementation and evidence-based recommendations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Role of radiotherapy in cancer control in low-income and middle-income countries.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Multinational assessment of some operational costs of teletherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

The effect of treatment interruptions in the postoperative irradiation of breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Guideline implementation for breast healthcare in low- and middle-income countries: treatment resource allocation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Lumpectomy Plus Tamoxifen or Anastrozole With or Without Whole Breast Irradiation in Women With Favorable Early Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Breast cancer in elderly women: can radiotherapy be omitted?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Can simulation measurements be used to predict the irradiated lung volume in the tangential fields in patients treated for breast cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Influence of radiation therapy on the lung-tissue in breast cancer patients: CT-assessed density changes and associated symptoms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Accuracy of ultrasound in localization of breast boost field

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Prospective evaluation of concomitant tumour bed boost with whole breast irradiation in patients with locally advanced breast cancer undergoing breast-conserving therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

The effect of timing of radiotherapy after breast-conserving surgery in patients with positive or close resection margins, young age, and node-negative disease, with long term follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Chemotherapy and radiation therapy for breast cancer: what is the optimal sequence?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Long-term outcome of adjuvant chemotherapy cyclophosphamide, mitoxantrone, and fluorouracil in women with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Sequencing of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Sequence of radiotherapy with tamoxifen in conservatively managed breast cancer does not affect local relapse rates

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Impact of concurrent versus sequential tamoxifen with radiation therapy in early-stage breast cancer patients undergoing breast conservation treatment.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Effects of tamoxifen on pulmonary fibrosis after cobalt-60 radiotherapy in breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Accelerated partial breast irradiation: an updated report from the American Brachytherapy Society

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Partial-breast irradiation: towards a replacement for whole-breast irradiation?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project random

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Quality assurance in breast cancer: EORTC experiences in the phase III trial on irradiation of the internal mammary nodes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

The role of postoperative radiotherapy in node negative breast cancer patients with pT3-T4 disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Patient subsets with T1-T2, node-negative breast cancer at high locoregional recurrence risk after mastectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Management of locally advanced breast cancer: evolution and current practice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Locally advanced breast cancer: treatment guideline implementation with particular attention to low- and middle-income countries

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Prospective randomised multicenter trial on single fraction radiotherapy (8 Gy x 1) versus multiple fractions (3 Gy x 10) in the treatment of painful bone metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Efficacy, toxicity, and cost-effectiveness of single-dose versus fractionated hemibody irradiation (HBI)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23838

7 January 2021

Identifiers

DOI

10.1002/CNCR.23838

1 reference

19 August 2017

1 reference